Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.15 -0.10 (-4.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xtl Biopharmaceuticals (XTLB) Other Accumulated Expenses (2009 - 2025)

Updated

Xtl Biopharmaceuticals' Other Accumulated Expenses was -$1.07 million in the quarter ended Jun 30, 2025.

Analysis

Xtl Biopharmaceuticals (XTLB) Other Accumulated Expenses (2009 - 2025) Analysis & Trends

As of Dec 31, 2011, Other Accumulated Expenses at Xtl Biopharmaceuticals came in at $541,000, down 28.8% from the prior year.

  • In earlier years, Other Accumulated Expenses was $760,000 in the year ended Dec 31, 2010 (+47.3%) and $516,000 in the year ended Dec 31, 2009.
  • The figure for the quarter ended Jun 30, 2025 marks the lowest quarterly Other Accumulated Expenses in data going back to the quarter ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Xtl Biopharmaceuticals 2.03 Bn 2.03 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.07 Mn
Sep 30, 2024 -284,000.00
Sep 30, 2012 847,000.00
Dec 31, 2011 541,000.00
Sep 30, 2011 525,000.00
Dec 31, 2010 760,000.00
Sep 30, 2010 687,000.00
Dec 31, 2009 516,000.00
API Access

Xtl Biopharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=XTLB&period=max&api_key=YOUR_API_KEY